PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20150637-2	2010	PATIENTS AND METHODS: With the aim of increasing patient"s lymphocyte count and reducing VEGF, wich could translate into an improved immune function and a better clinical outcome, patients with HRBC, received HDCT, PBPCT and immunotherapy with interleukin-2 (IL-2) and 13-cis retinoic acid (RA).	Isotretinoin	269-289	vascular endothelial growth factor A	Homo sapiens	89-93